Since January 2025, the regulatory landscape for tobacco and nicotine products in the United States...
The Role of AI and Technology in Accelerating PMTA Reviews
As the U.S. Food and Drug Administration (FDA) seeks to modernise its regulatory processes, technology is emerging as a cornerstone of its strategy, particularly in addressing the long-standing challenges of the premarket tobacco product application...
Results - 99 Blogs
When developing a nicotine product, the choice between freebase nicotine and nicotine salts plays a...
Chromatography is a cornerstone of analytical testing for nicotine products. It allows us to...
Our Chief Commercial Officer, Andy Mooney, recently attended the Global Forum on Nicotine (GFN)...
The Next Generation Nicotine Delivery (NGND) conference in Miami delivered an energetic and...
Introduction: Preparing for Regulatory Change in the Vape Industry
The inaugural ATNF conference, held from 15–17 April 2025, brought together stakeholders across the...
As global economic dynamics shift, the reduced-risk nicotine industry, already contending with...
EVO NXT 2025 in Milan offered a refreshing departure from traditional large-scale expos. The event...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
